Kidney Stone Management Market to Reach $2.21 Billion by 2027: Advent of Innovations Such as Holmium Laser Technologies to Bode Well

The global kidney stone management market size is anticipated to touch USD 2.21 billion by 2027 attributable to the increasing prevalence of kidney stone cases. This, coupled with the advent of the latest innovations in diagnostic procedures such as disposable ureteroscopes, minimally invasive surgeries, and holmium laser technologies are boosting the market growth. A recent report by Fortune Business Insights, titled, “Kidney Stone Management Market Size, Share & COVID-19 Impact Analysis, By Type (Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithonomy (PCNL) By End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Regional Forecast, 2020-2027,” states that the value of this market was USD 1.47 billion in the year 2019. The forecast period is set between 2020 to 2027, and the market is expected to exhibit a CAGR of 5.3%.

LithoVue Empower™ Retrieval Deployment Device Launched by Boston Scientific will Pave a new Direction to Advanced Uterescopy

A leading manufacturer of medical devices named Boston Scientific Corporation announced the launch of its new kidney stone retrieval device called LithoVue Empower™ Retrieval Deployment in September 2018. This new device is created for operations in collaboration with the LithoVue™ Single-Use Digital Flexible Ureteroscope, produced by the same company for assisting urologists in performing ureteroscopy efficiently.

Dr Brian Matlaga, a professor of Urology at John Hopkins Medical Institutions, said, “The new LithoVue Empower Device will enhance the procedural bottlenecks at the time of kidney stone removal diagnostic processes. We guarantee quality care at a reduced cost of the procedure and excellent patient outcomes. We are aiming for the evolution of urologic and pelvic condition treatment.” Such innovations are expected to bode well for the urolithiasis management market in the forthcoming years.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/kidney-stone-management-devices-market-100450

Increasing Popularity of Holmium Laser Technology will Add Impetus

The increasing prevalence of kidney stone worldwide is a key factor promoting the kidney stone treatment devices market growth. This, coupled with the growing popularity of minimally invasive surgeries, holmium laser technology, benign prostatic hyperplasia (BPH) treatment, and other innovative stone removal devices, are also driving the market for kidney stone management devices.

However, the current COVID-19 pandemic, coupled with the side effects associated with opting for these devices such as urine blockage as a result of broken stones, a rise in the arterial blood pressure, infections, and others may cause major hindrances to the market. Nevertheless, the advent of MOSES technology is expected to help in increase its demand in the market during the forecast period.

Boston Scientific, Richard Wolf GmbH KARL STORZ, and Olympus Corporation Holding Prominent Share Owing to Diverse Portfolio

The global urinary stone treatment devices market is dominated by a few players, namely, KARL STORZ SE & Co. KG, Richard Wolf GmbH, Olympus Corporation, and Boston Scientific Corporation. The growth of these companies is attributed to the vast geographical expansion, which helped them in establishing their brands. The other players are engaging in joint ventures and combined contracts for gaining a significant position in the market competition.

Key Industry Developments of Kidney Stone Treatment Devices Market Include:

• October 2017 – MOSES holmium technology was launched by Lumenis for applications in the urology department in India to expand its geographical reach and gain a significant position in the international market.

List of Prominent Players in the Market Include:

• DirexGroup (Germany)


• Cook Medical Inc. (US)


• EDAP TMS (France)


• Boston Scientific Corporation (US)


• Lumenis (Israel)


• Olympus Corp. (Japan)


• STORZ MEDICAL AG (Switzerland)


• C.R. Bard Inc. (BD) (US)


• Richard Wolf GmbH (Germany)


• Other Players

Further Report Findings:

• North America earned USD 555.7 million in terms of revenue in 2019 and emerged dominant owing to the increasing adoption of innovative devices and the availability of reimbursement policies.


• Based on segmentation by type, the ureteroscopes segment earned 51.51% kidney stone management market share in 2019 and emerged dominant. This is owing to the low recurrence rate that increased its popularity among the patient pool.

The Global Kidney Stone Management Market is categorized into: